Vir’s shares jumped 35% before the bell, while GSK was up about 1%. Drugmakers across the globe are rushing to develop a treatment or vaccine for the fast-spreading coronavirus that has killed over 68,400 people globally. There are currently no approved treatments for the disease. …read more
Source:: Yahoo Finance
